Lineage Cell Therapeutics (LCTX) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Lineage Cell Therapeutics | 270.71 Mn | 213.99 Mn | 1.07 Mn | 252.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 252.91 Mn |
| Mar 31, 2026 | 249.30 Mn |
| Dec 31, 2025 | 243.12 Mn |
| Sep 30, 2025 | 230.33 Mn |
| Jun 30, 2025 | 228.36 Mn |
| Mar 31, 2025 | 228.36 Mn |
| Dec 31, 2024 | 220.42 Mn |
| Sep 30, 2024 | 188.84 Mn |
| Jun 30, 2024 | 188.82 Mn |
| Mar 31, 2024 | 188.75 Mn |
| Dec 31, 2023 | 174.99 Mn |
| Sep 30, 2023 | 174.99 Mn |
| Jun 30, 2023 | 174.44 Mn |
| Mar 31, 2023 | 170.17 Mn |
| Dec 31, 2022 | 170.09 Mn |
| Sep 30, 2022 | 169.89 Mn |
| Jun 30, 2022 | 169.75 Mn |
| Mar 31, 2022 | 169.73 Mn |
| Dec 31, 2021 | 169.48 Mn |
| Sep 30, 2021 | 168.47 Mn |